Form 4: Nuvalent Director Emily Conley Executes Stock Option and Sells Shares Under 10b5-1 Plan

Director Emily Conley exercised stock options and sold Nuvalent (NUVL) shares on June 14, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On June 14, 2024, Emily Conley, a director at Nuvalent, Inc. (NUVL), executed a transaction involving the company's stock.
• Conley exercised a stock option to acquire 5,000 shares of Class A Common Stock at a price of $13.79 per share.
• Simultaneously, Conley sold 4,777 shares at a weighted average price of $77.52 and 223 shares at a weighted average price of $78.31.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 13, 2023.
• Following these transactions, Conley directly owns 2,507 shares of Class A Common Stock and holds options for 31,667 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing trading plan, without indicating any particular positive or negative outlook.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. These filings provide transparency to the market regarding insider activity.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the trades mitigates concerns about insider information.

Key Dates